Takeda's QDENGA Becomes India's First Approved Dengue Vaccine

CDSCO greenlights the tetravalent TAK-003 shot for ages 4+, no pre-screening required—a potential game-changer for a country logging millions of dengue cases each year.

ndtv-profit-business · 7/20/2026, 12:32:51 PM · Ask about this →